StonvexLoading…
StonvexStonvexStonvexCore line items from ACA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.88B | $2.57B | $2.31B | $2.24B |
Operating Income | $341.90M | $197.60M | $217.30M | $349.00M |
Net Income | $208.40M | $93.70M | $159.20M | $245.80M |
EPS (Diluted) | $4.24 | $1.91 | $3.26 | $5.05 |
Total Assets | $4.99B | $4.92B | $3.58B | $3.34B |
Total Liabilities | $2.34B | $2.49B | $1.25B | $1.16B |
Cash & Equivalents | $214.60M | $187.30M | $104.80M | $160.40M |
Free Cash Flow OCF − CapEx | $175.50M | $312.30M | $57.50M | $36.30M |
Shares Outstanding | 49.00M | 48.80M | 48.60M | 48.40M |